STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

BMY BRISTOL MYERS SQUIBB COMPANY StockScouter® Report

7

StockScouter® Score

BRISTOL MYERS SQUIBB COMPANY, a large cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated rapidly compared to earnings growth in the past three years. Positive
  • The 50-day moving average for BMY is significantly above its 200-day moving average. Positive

 

Concerns

  • Two or more executives, directors or major shareholders sold a large number of shares recently. Very negative
  • One or more analysts has modestly decreased quarterly earnings estimates for BMY. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that large cap stocks will be neutral, growth stocks will be in favor, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 20% done.
Progress: 80% done.
Low
High

Core Model Grades

A
F
C
B

Previous Ratings

8
8
7